DeepMatter Group Plc (AIM: DMTR, “Deepmatter”, the “Group”), the digital chemistry data and software company, has signed a multiyear database license agreement with Merck, a leading science and technology company,
DeepMatter Group PLC (DMTR.L) Placing, Subscription and Open Offer
DeepMatter Group Plc (AIM: DMTR) (“DeepMatter” the “Company” or the “Group”), the international digital chemistry data company , today announces a placing and subscription to raise gross proceeds o f
Are Deepmatter Double Reporting By Announcing Trials with Dr Reddys and a Subsidiary ?
DeepMatter Group PLC today announced it has signed a contract to trial its DigitalGlassware® platform with Aurigene Pharmaceutical Services based in Hyderabad, India, to supply its DigitalGlassware® platform.
Deepmatter Competitor PathAI Welcomed by Roche into its open digital pathology initiative
Roche has selected PathAI to collaborate with it on an artificial intelligence program that will be merged with its digital pathology work.
The rise of robots and automation in the Chemistry Lab
Automated chemistry has been a priority for many companies since the outbreak of the pandemic. Paul Whittles is the sales director at Deepmatter Group (a company based in Glasgow, UK
DeepMatter Group PLC (DMTR.L) collaborates with Dr. Reddy’s for its DigitalGlassware® platform
DeepMatter Group Plc (AIM: DMTR, “DeepMatter”, the “Group”), the international digital chemistry data company, has signed a contract with Dr. Reddy’s Laboratories Limited (“Dr. Reddy’s”), based in Hyderabad, India, for
Deepmatter Group plc (DMTR.L) Half Year Webinar Q and A
The following Q&A comes from the recent DeepMatter Group Plc Half Year Results Webinar
£400m Life Sciences hub in Stevenage To Be Built By GSK creating up to 5000 jobs
GSK, the pharmaceutical giant, plans to open a PS400m science hub at Stevenage. This could lead to up to 5,000 new jobs. Work is expected to start in 2022.
GLASGOW-based technology business DeepMatter has been chosen to work with English universities
On a project it is hoped could help speed the development of new vaccines and of anti-cancer drugs
DeepMatter Group PLC (DMTR.L) Collaborates with the Universities of Leeds and Sheffield
DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, has been selected as a partner for the University of Leeds following a £1.4M EPSRC investment they received to develop
DeepMatter Group PLC (DMTR.L) Posting of ARA and Updated Notice of AGM
DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, confirms that the Annual Report and Accounts for the year ended 31 December 2020 and the Notice of Annual General